Radiotherapy Market Share Report | Trends, Size & Forecasts 2028
[Research Report] The radiotherapy market is projected to reach US$ 10,170.80 million by 2028 from US$ 6,474.78 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028.
Market Insights and Analyst View:
Radiotherapy, also known as radiation therapy, is a medical treatment that utilizes high-energy radiation to target and destroy malignant (cancerous) cells. It is a crucial component of cancer treatment and is employed to either cure cancer, control its growth, or alleviate symptoms. Radiotherapy often involves ionizing radiation, such as X-rays or gamma rays, to attack cancer cells and hinder their ability to grow and multiply. It can be administered externally using a machine that directs radiation toward the cancerous area (external beam radiotherapy) or internally by inserting a radioactive source within the body near the affected cells (brachytherapy). The goal of radiotherapy is to deliver precisely targeted doses of radiation to the tumor, minimizing damage to surrounding healthy tissue while maximizing its effect on cancer cells. Radiotherapy is employed in conjunction with other cancer treatments, such as surgery and chemotherapy. It is administered with careful consideration of the cancer type, its stage, and the patient's overall health. Thus, radiotherapy plays a vital role in the comprehensive management of cancer, offering an effective and localized approach to treating tumors while striving to preserve healthy tissue and improve patient outcomes.
Growth Drivers and Opportunities:
The primary drivers of the radiotherapy market's growth are the increasing cases of cancer patients, huge government and non-government investments in R&D of cancer treatment, and the growing need to reduce healthcare costs. The world is witnessing a significant rise in the number of cancer patients. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with approximately 10 million deaths reported in 2022. Among all cancer types, breast cancer is considered the most common cancer among women worldwide, and its incidence is increasing globally. Factors such as lifestyle changes, hormonal imbalances, genetic predisposition, and environmental factors contribute to the rising prevalence of breast cancer. Per the American Cancer Society, approximately 5–10% of all malignancies are caused by genes inherited from parents. Several cancer-predisposition genes have been discovered. For instance, mutations in the inherited cancer predisposition genes BRCA1 and BRCA2 raise the risk of getting certain malignancies, such as breast, ovarian, and prostate cancer.
In addition, breast cancer is one of the most common types of cancer in the US. A report published by Breastcancer.org in January 2022 stated that 1 in 8 women in the nation (or ~13%) will acquire invasive breast cancer over their lifetime. According to the same source, 287,850 new incidences of invasive breast cancer, along with 51,400 new cases of non-invasive (in situ) breast cancer, are anticipated to be detected in women in the US in 2022. In the same year, the country is anticipated to record ~2,710 additional cases of invasive breast cancer in men. Approximately 1 in 833 men might develop breast cancer in their lives. With the rise in breast cancer cases, there is an increasing need for effective and targeted therapies to improve patient outcomes. This has led to a surge in research and development activities in breast cancer therapeutics. The rising incidence of breast cancer has underscored the essential role of radiotherapy in the comprehensive treatment of this prevalent malignancy. As the number of individuals diagnosed with breast cancer continues to increase, radiotherapy stands as a critical modality within the multidisciplinary approach to cancer care. Radiotherapy plays a pivotal role in the management of breast cancer, serving various purposes, such as postsurgical treatment to eradicate residual cancer cells, neoadjuvant therapy to shrink tumors before surgery, and adjuvant therapy to reduce the risk of cancer recurrence. Additionally, radiotherapy is employed to alleviate symptoms and improve outcomes for advanced or metastatic breast cancer.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiotherapy Market: Strategic Insights
Market Size Value in US$ 6,474.78 million in 2020 Market Size Value by US$ 10,170.80 million by 2028 Growth rate CAGR of 5.9% from 2021 to 2028. Forecast Period 2021-2028 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiotherapy Market: Strategic Insights
| Market Size Value in | US$ 6,474.78 million in 2020 |
| Market Size Value by | US$ 10,170.80 million by 2028 |
| Growth rate | CAGR of 5.9% from 2021 to 2028. |
| Forecast Period | 2021-2028 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
On the other hand, the lack of skilled personnel to perform radiotherapy is a significant bottleneck that constrains the growth and accessibility of radiation therapy services, particularly in regions facing healthcare workforce shortages. Skilled radiation oncologists, medical physicists, radiation therapists, and dosimetrists are essential for effectively and safely administering radiotherapy. However, a global shortage of these highly specialized professionals has limited the capacity of healthcare facilities to deliver crucial radiation treatments, leading to increased patient waiting times, suboptimal treatment access, and a strain on the healthcare system.
Consequently, the shortage of skilled personnel hampers the expansion and reach of the radiotherapy market, reducing the potential for broader adoption and utilization of radiotherapy services in various healthcare settings. The limited availability of skilled professionals impedes the capacity to provide timely and optimal radiation treatment for cancer patients. It impacts the ability of healthcare facilities to leverage advanced radiotherapy technologies and techniques fully. Additionally, multi-stakeholder collaborations, international partnerships, and the establishment of supportive frameworks for professional development are pivotal in addressing the lack of skilled personnel, enabling the expansion and efficacy of radiotherapy services, and ensuring that patients have access to the critical treatments they require.
Report Segmentation and Scope:
The “Global radiotherapy market” is segmented based on the type, application, end-user, and region. The radiotherapy market is broadly segmented into systemic, external beam, and internal radiation therapy. The radiotherapy market is classified based on applications, such as skin and lip cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. The end-user segment of the radiotherapy market is broadly segmented into hospitals, ambulatory and radiotherapy centers, and others. The radiotherapy market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
Segmental Analysis:
Based on the type, the radiotherapy market is segmented into external beam, internal, and systemic radiation therapy. In 2022, the radiotherapy market revenue was mostly attributed to external beam radiation therapy, which had the largest share. The global radiation treatment market is expected to grow during the forecast period due to rising cancer incidence and prevalence rates in both developed and developing nations, technical developments, and increased healthcare spending. To enhance patient outcomes, cancer centers are expanding the availability of external beam radiation therapies, including stereotactic radiosurgery, intensity-modulated radiation therapy (IMRT), and 3-D conformal radiation therapy. Healthcare firms can expand their research and development efforts in radiation therapy for cancer because of these therapy choices.
Based on the cancer segment, the radiotherapy market is segmented into skin and lip cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. Skin cancer, which includes squamous cell carcinoma, melanoma, and basal cell carcinoma, mostly develops in skin cells as a result of exposure to ultraviolet (UV) light. The three main causes of lip cancer are smoking, immune system compromise, and UV radiation exposure. A significant growth in the skin and lip cancer segment is anticipated throughout the projected period. Growing incidence of skin and lip cancer, substantial R&D pipelines, improvements in radiation technology, rising demand for non-invasive cancer treatments like radiotherapy, and expanding access to radiotherapy services globally are some factors propelling the segment's growth. For example, by the end of 2023, the United States will have detected 97,610 cases of melanomas, with 58,120 males and 39,490 women, according to data from the American Cancer Society in January 2023. Therefore, there will be a considerable need for radiation devices for therapeutic reasons due to the increased prevalence of skin and lip cancer, which will fuel market expansion.
Based on the end user, the radiotherapy market is classified into hospitals, ambulatory and radiotherapy centers, and others. Throughout the forecast period, the hospital segment is expected to have a significant global market share. This is explained by an increase in the number of cancer patients and an increase in the use of different radiation treatments in hospitals.
Regional Analysis:
Based on geography, the global radiotherapy market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
North America is anticipated to witness notable expansion in the radiation therapy market throughout the forecast period. The rising incidence and prevalence of cancer, major companies in the area, and the introduction of innovative products all contribute to the market's expansion. The American Cancer Society's most frequent cancer among women in the US is breast cancer, according to data updated in January 2023. It represents one in three, or 30%, of all newly diagnosed female cancers in the nation each year. The same source projects that by the end of 2023, women will receive new diagnoses for 297,790 cases of invasive breast cancer and 55,720 cases of ductal carcinoma in situ (DCIS). It is expected that the cancer burden will drive the nation's need for radiation therapy. As a result, the country's high cancer incidence and prevalence necessitate the development of sophisticated radiation treatments, which is also expected to fuel the region's overall market expansion.
Furthermore, the major regional players are actively involved in several advances linked to radiotherapy, fueling the expansion of the regional market. For example, SkinCure Oncology announced in September 2021 that positive data (99.3% cure rate) for Image-Guided Superficial Radiotherapy (IGSRT) in treating squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) had been obtained from a clinical trial. Furthermore, GE Healthcare presented 15 cutting-edge multi-modality radiation treatment solutions in October 2021 at the American Society for Radiation Oncology's 2021 event to enhance patient-centered care and advance precision medicine. The demand for radiotherapy in the nation is anticipated to increase due to these recent breakthroughs, propelling the expansion of the regional market as a whole.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global radiotherapy market are listed below:
In May 2023, GE HealthCare launched three new products that highlight the radiation oncology care pathway, which includes Intelligent Radiation Therapy (IRT), Auto Segmentation, and an upgraded Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite). To assist patients in leading the healthiest lives possible, each of these cutting-edge solutions—which will be on display at the European Society for Therapeutic Radiology and Oncology 2023 Congress—was created to enable physicians to deliver the highest caliber of individualized care by giving them access to the data, technologies, and diagnostics they need to make well-informed decisions.
In February 2023, RefleXion Medical received US FDA approval for SCINTIX biology-guided radiotherapy, a cutting-edge treatment for early and late-stage cancers.
Radiotherapy Market Report Scope
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global radiotherapy market are GE Healthcare, GE Healthcare, Elekta, ViewRay Technologies, Inc., Accuray Incorporated, Isoray Inc., Hitachi, Ltd., ALCEN (PMB), Siemens Healthineers AG, and amongst others. These radiotherapy markets focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, allowing them to serve many customers and subsequently increase their market share. The report offers radiotherapy market trends analysis emphasizing various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading global market players.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Product, Application, and End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Radiotherapy is majorly used to control the growth of a tumor while restricting the harm to nearby normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung, and any other parts in the body where radiation treatment is indicated.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of cancer and rising number of conferences and symposiums to boost the awareness about radiation therapy. However, increased risk of adverse effects due to radiation therapy restrains the market growth.
The radiotherapy market majorly consists of the players such as Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems amongst others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Radiotherapy Market – By Type
1.3.2 Global Radiotherapy Market – By Product
1.3.3 Global Radiotherapy Market – By Application
1.3.4 Global Radiotherapy market – By End User
1.3.5 Global Radiotherapy market – By Geography
2. Radiotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Radiotherapy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.1 Expert Opinions
5. Radiotherapy Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer Worldwide
5.1.2 Increasing Number of Conferences and Symposiums to Boost Awareness About Radiation Therapy
5.2 Market Restraints
5.2.1 Increased Risk of Adverse Effects due to Radiation Therapy
5.3 Market Opportunities
5.3.1 Cancer Screening Programs and Implementation of Standard Guidelines
5.4 Future Trends
5.4.1 Emphasis on Reduced Radiation Exposure Therapies
5.5 Impact Analysis
6. Radiotherapy Market – Global Analysis
6.1 Global Radiotherapy Market Revenue Forecast And Analysis
6.2 Global Radiotherapy Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Radiotherapy Market Analysis – By Type
7.1 Overview
7.2 Radiotherapy Market Revenue Share, by Type (2020 and 2028)
7.3 External-Beam Radiation Therapy
7.3.1 Overview
7.3.2 External-Beam Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Internal Radiation Therapy
7.4.1 Overview
7.4.2 Internal Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Systemic Radiotherapy/Radiopharmaceuticals
7.5.1 Overview
7.5.2 Radiotherapy/Radiopharmaceuticals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8. Radiotherapy Market Analysis – By Product
8.1 Overview
8.2 Radiotherapy Market Revenue Share, by Product (2020 and 2028)
8.3 External Beam Radiotherapy Products
8.3.1 Overview
8.3.2 External Beam Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Internal Radiotherapy Products
8.4.1 Overview
8.4.2 Internal Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Radiotherapy Software
8.5.1 Overview
8.5.2 Radiotherapy Software: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Radiotherapy Market Analysis – By Application
9.1 Overview
9.2 Radiotherapy Market Revenue Share, by Application (2020 and 2028)
9.3 Breast Cancer
9.3.1 Overview
9.3.2 Breast Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Lung Cancer
9.4.1 Overview
9.4.2 Lung Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Prostate Cancer
9.5.1 Overview
9.5.2 Prostate Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Colorectal Cancer
9.6.1 Overview
9.6.2 Colorectal Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Lymphoma
9.7.1 Overview
9.7.2 Lymphoma: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Liver Cancer
9.8.1 Overview
9.8.2 Liver Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Thyroid Cancer
9.9.1 Overview
9.9.2 Thyroid Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.10 Brain Cancer
9.10.1 Overview
9.10.2 Brain Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.11 Cervical Cancer
9.11.1 Overview
9.11.2 Cervical Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.12 Spine Cancer
9.12.1 Overview
9.12.2 Spine Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.13 Others
9.13.1 Overview
9.13.2 Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Radiotherapy Market Analysis – By End User
10.1 Overview
10.2 Radiotherapy Market Share, by End User, 2020 and 2028, (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Radiation Therapy Centres
10.4.1 Overview
10.4.2 Radiation Therapy Centres: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Radiotherapy Market – Geographic Analysis
11.1 North America: Radiotherapy Market
11.1.1 Overview
11.1.2 North America: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.1.4 North America: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.1.5 North America: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.1.6 North America: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.1.7 North America: Radiotherapy Market, by Country, 2020 & 2028 (%)
11.1.7.1 US: Radiotherapy Market– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.1.7.1.3 US: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.1.7.1.4 US: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.1.7.1.5 US: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.1.7.2 Canada: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.1.7.2.3 Canada: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.1.7.2.4 Canada: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.1.7.2.5 Canada: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.1.7.3 Mexico: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico Radiotherapy Market, by Type – 2019–2028 (USD Million)
11.1.7.3.3 Mexico Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.1.7.3.4 Mexico Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.1.7.3.5 Mexico Radiotherapy Market, by End User – 2019–2028 (USD Million)
11.2 Europe: Radiotherapy Market
11.2.1 Overview
11.2.2 Europe: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.4 Europe: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.5 Europe: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.6 Europe: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.2.7 Europe: Radiotherapy Market, by Country, 2020 & 2028(%)
11.2.7.1 Germany: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.1.1 Germany: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.1.2 Germany: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.7.1.3 Germany: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.7.1.4 Germany: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.7.1.5 Germany: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.2.7.2 France: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.2.1 France: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.2.2 France: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.7.2.3 France: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.7.2.4 France: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.7.2.5 France: Radiotherapy Market, End User– 2019–2028 (USD Million)
11.2.7.3 UK: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.3.1 UK: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.3.2 UK: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.7.3.3 UK: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.7.3.4 UK: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.7.3.5 UK: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.2.7.4 Italy: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.4.1 Italy: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.4.2 Italy: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.7.4.3 Italy: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.7.4.4 Italy: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.7.4.5 Italy: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.2.7.5 Spain: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.5.1 Spain: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.5.2 Spain: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.7.5.3 Spain: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.7.5.4 Spain: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.7.5.5 Spain: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.2.7.6 Rest of Europe: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.6.1 Rest of Europe: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.2.7.6.2 Rest of Europe: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.2.7.6.3 Rest of Europe: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.2.7.6.4 Rest of Europe: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.2.7.6.5 Rest of Europe: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3 Asia Pacific: Radiotherapy Market
11.3.1 Overview
11.3.2 Asia-Pacific: Radiotherapy Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia-Pacific: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.4 Asia-Pacific: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.5 Asia-Pacific: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.3.6 Asia-Pacific: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3.7 Asia-Pacific: Radiotherapy Market, by Country, 2020 & 2028 (%)
11.3.7.1 China: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.7.1.3 China: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.7.1.4 China: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.3.7.1.5 China: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3.7.2 Japan: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.7.2.3 Japan: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.7.2.4 Japan: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.3.7.2.5 Japan: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3.7.3 India: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.7.3.3 India: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.7.3.4 India: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.3.7.3.5 India: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3.7.4 Australia: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 Australia: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 Australia: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.7.4.3 Australia: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.7.4.4 Australia: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.3.7.4.5 Australia: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3.7.5 South Korea: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 South Korea: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 South Korea: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.7.5.3 South Korea: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.7.5.4 South Korea: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.3.7.5.5 South Korea: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.3.7.6 Rest of Asia-Pacific: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia-Pacific: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia-Pacific: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.3.7.6.3 Rest of Asia-Pacific: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.3.7.6.4 Rest of Asia-Pacific: Radiotherapy Market, by Application, by Radiotherapy, 2019–2028 (USD Million)
11.3.7.6.5 Rest of Asia-Pacific: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.4 Middle East & Africa: Radiotherapy Market
11.4.1 Overview
11.4.2 Middle East & Africa: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East & Africa Radiotherapy Market, by Type – 2019–2028 (USD Million)
11.4.4 Middle East & Africa Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.4.5 Middle East & Africa Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.4.6 Middle East & Africa Radiotherapy Market, by End User – 2019–2028 (USD Million)
11.4.7 Middle East & Africa: Radiotherapy Market, by Country, 2020 & 2028 (%)
11.4.7.1 Saudi Arabia: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Saudi Arabia: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Saudi Arabia Radiotherapy Market, by Type – 2019–2028 (USD Million)
11.4.7.1.3 Saudi Arabia Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.4.7.1.4 Saudi Arabia Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.4.7.1.5 Saudi Arabia Radiotherapy Market, by End User – 2019–2028 (USD Million)
11.4.7.2 UAE: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 UAE: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 UAE Radiotherapy Market, by Type – 2019–2028 (USD Million)
11.4.7.2.3 UAE Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.4.7.2.4 UAE Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.4.7.2.5 UAE Radiotherapy Market, by End User – 2019–2028 (USD Million)
11.4.7.3 South Africa: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 South Africa: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 South Africa Radiotherapy Market, by Type – 2019–2028 (USD Million)
11.4.7.3.3 South Africa Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.4.7.3.4 South Africa Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.4.7.3.5 South Africa Radiotherapy Market, by End User – 2019–2028 (USD Million)
11.4.7.4 Rest of Middle East and Africa: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.1 Rest of Middle East & Africa: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.2 Rest of Middle East and Africa Radiotherapy Market, by Type– 2019–2028 (USD Million)
11.4.7.4.3 Rest of Middle East and Africa Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.4.7.4.4 Rest of Middle East and Africa Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.4.7.4.5 Rest of Middle East and Africa Radiotherapy Market, by End User – 2019–2028 (USD Million)
11.5 South and Central America: Radiotherapy Market
11.5.1 Overview
11.5.2 South and Central America: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.5.4 South and Central America: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.5.5 South and Central America: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.5.6 South and Central America: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.5.7 South and Central America: Radiotherapy Market, by Country, 2020 & 2028 (%)
11.5.7.1 Brazil: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Brazil: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.2 Brazil: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.5.7.1.3 Brazil: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.5.7.1.4 Brazil: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.5.7.1.5 Brazil: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.5.7.2 Argentina: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Argentina: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.2 Argentina: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.5.7.2.3 Argentina: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.5.7.2.4 Argentina: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.5.7.2.5 Argentina: Radiotherapy Market, End User, 2019–2028 (USD Million)
11.5.7.3 Rest of South and Central America: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.5.7.3.4 Rest of South and Central America: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.5.7.3.5 Rest of South and Central America: Radiotherapy Market, End User, 2019–2028 (USD Million)
12. Impact of COVID-19 Pandemic on Global Radiotherapy Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
12.2 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.3 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Siemens Healthineers AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Accuray Incorporated
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sumitomo Heavy Industries, Ltd.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Elekta AB
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Hitachi, Ltd.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Koninklijke Philips N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Brainlab AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 PROTOM INTERNATIONAL
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Varian Medical Systems, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Maastro
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Mevion Medical Systems
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. US Radiotherapy Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 7. US Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. US Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Radiotherapy Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Radiotherapy Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Europe: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 19. Europe: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Europe: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Germany: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 23. Germany: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Germany: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 25. France: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 26. France: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 27. France: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 28. France: Radiotherapy Market, End User– Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 30. UK: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 31. UK: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 32. UK: Radiotherapy Market, End User– Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 34. Italy: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 35. Italy: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 36. Italy: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 38. Spain: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 39. Spain: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 40. Spain: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe: Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 45. Asia-Pacific Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 46. Asia-Pacific: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 47. Asia-Pacific Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Asia-Pacific Radiotherapy Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 49. China: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 50. China: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 51. China: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 52. China: Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 54. Japan: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Japan: Radiotherapy Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 57. India: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 58. India: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 59. India: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. India: Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 62. Australia: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Australia: Radiotherapy Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea: Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia-Pacific: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia-Pacific: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia-Pacific: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia-Pacific: Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East & Africa Radiotherapy Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Radiotherapy Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 79. Saudi Arabia Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 80. Saudi Arabia Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 81. UAE Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 82. UAE Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 83. UAE Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 84. UAE Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa Radiotherapy Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 86. South Africa Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 88. South Africa Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East and Africa Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East and Africa Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East and Africa Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 92. Rest of Middle East and Africa Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 96. South and Central America: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 100. Brazil: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 104. Argentina: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America: Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America: Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of South and Central America: Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of South and Central America: Radiotherapy Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 1. Organic Developments Done By Companies
Table 2. Inorganic Developments Done By Companies
Table 3. Glossary of Terms, Radiotherapy Market
LIST OF FIGURES
Figure 1. Radiotherapy Market Segmentation
Figure 2. Radiotherapy Market Segmentation, By Region
Figure 3. Radiotherapy Market Overview
Figure 4. External-Beam Radiation Therapy Segment Held Largest Share of Radiotherapy Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Radiotherapy Market, by Geography (US$ Million)
Figure 7. Global Radiotherapy Market – Leading Country Markets (US$ Million)
Figure 8. Global Radiotherapy Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Radiotherapy Market Impact Analysis of Drivers and Restraints
Figure 15. Global Radiotherapy Market – Revenue Forecast And Analysis – 2020- 2028
Figure 16. Global Radiotherapy Market – By Geography Forecast and Analysis – 2020- 2028
Figure 17. Market Positioning of Key Players In Global Radiotherapy Market
Figure 18. Radiotherapy Market Revenue Share, by Type (2020 and 2028)
Figure 19. Externa-Beam Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Internal Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Radiotherapy/Radiopharmaceuticals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Radiotherapy Market Revenue Share, by Product (2020 and 2028)
Figure 23. External Beam Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Internal Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Radiotherapy Software: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Radiotherapy Market Revenue Share, by Application (2020 and 2028)
Figure 28. Breast Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Lung Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Prostate Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Colorectal Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Lymphoma: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Liver Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Thyroid Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Brain Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Cervical Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Spine Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Radiotherapy Market Share, by End User, 2020 and 2028 (%)
Figure 40. Hospitals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Radiation Therapy Centers: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Specialty Clinics: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. North America: Radiotherapy Market, by Key Country – Revenue (2020) (USD Million)
Figure 44. North America Radiotherapy Market Revenue and Forecast to 2028 (USD Million)
Figure 45. North America: Radiotherapy Market, by Country, 2020 & 2028 (%)
Figure 46. US: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Canada: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Mexico: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Europe: Radiotherapy Market, by Key Country – Revenue (2020) (USD Million)
Figure 50. Europe: Radiotherapy Market Revenue and Forecast to 2028 (USD Million)
Figure 51. Europe: Radiotherapy Market, by Country, 2020 & 2028 (%)
Figure 52. Germany: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. France: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. UK: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Italy: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Spain: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Rest of Europe: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Asia-Pacific: Radiotherapy Market, by Key Country – Revenue (2020) (USD Million)
Figure 59. Asia-Pacific Radiotherapy Market Revenue and Forecast to 2028 (USD Million)
Figure 60. Asia-Pacific: Radiotherapy Market, by Country, 2020 & 2028 (%)
Figure 61. China: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Japan: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. India: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Australia: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. South Korea: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Asia-Pacific: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Middle East & Africa: Radiotherapy Market, by Key Country – Revenue (2019) (USD Million)
Figure 68. Middle East & Africa Radiotherapy Market Revenue and Forecast to 2028 (USD Million)
Figure 69. Middle East & Africa: Radiotherapy Market, by Country, 2020 & 2028 (%)
Figure 70. Saudi Arabia: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 71. UAE: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 72. South Africa: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. South Africa: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. South and Central America: Radiotherapy Market, by Key Country – Revenue (2020) (USD Million)
Figure 75. South and Central America Radiotherapy Market Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Radiotherapy Market, by Country, 2020 & 2028 (%)
Figure 77. Brazil: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 78. Argentina: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 79. Rest of South and Central America: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 80. Impact of COVID-19 Pandemic on Radiotherapy Market in North American Countries
Figure 81. Impact of COVID-19 Pandemic on Radiotherapy Market in European Countries
Figure 82. Impact of COVID-19 Pandemic on Radiotherapy Market in Asia Pacific Countries
Figure 83. Impact of COVID-19 Pandemic on Radiotherapy Market in Rest of the World
Figure 84. Impact of COVID-19 Pandemic on Radiotherapy Market in Rest of the World
Figure 1. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Radiotherapy Market
- Siemens Healthineers AG
- Accuray Incorporated
- Sumitomo Heavy Industries, Ltd.
- Elekta AB
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Brainlab AG
- PROTOM INTERNATIONAL
- Varian Medical Systems, Inc.
- Maastro
- Mevion Medical Systems
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For